Axonics Sacral Neuromodulation System

Stimulator, Electrical, Implantable, For Incontinence

FDA Premarket Approval P180046

Pre-market Approval Supplement Details

Approval for the axonics sacral neuromodulation system. The device is indicated for the treatment of urinary retention and the symptoms of overactive bladder, including urinary urge incontinence and significant symptoms of urgency-frequency alone or in combination, in patients who have failed or could not tolerate more conservative treatments.

DeviceAxonics Sacral Neuromodulation System
Classification NameStimulator, Electrical, Implantable, For Incontinence
Generic NameStimulator, Electrical, Implantable, For Incontinence
ApplicantAxonics Modulation Technologies, Inc.
Date Received2018-12-06
Decision Date2019-11-13
Notice Date2019-11-14
PMAP180046
SupplementS
Product CodeEZW
Docket Number19M-5393
Advisory CommitteeGastroenterology/Urology
Expedited ReviewNo
Combination Product No
Applicant Address Axonics Modulation Technologies, Inc. 26 Technology Drive irvine, CA 92618
Summary:Summary of Safety and Effectiveness
Labeling: Labeling Labeling Part 2
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P180046Original Filing
S064 2023-01-10 30-day Notice
S063
S062 2022-09-29 Normal 180 Day Track
S061 2022-09-19 Normal 180 Day Track
S060 2022-08-15 30-day Notice
S059 2022-08-11 30-day Notice
S058
S057 2022-06-30 30-day Notice
S056
S055 2022-04-15 30-day Notice
S054
S053
S052 2022-03-24 30-day Notice
S051 2022-02-07 30-day Notice
S050 2022-01-14 30-day Notice
S049 2022-01-05 30-day Notice
S048
S047 2021-12-15 30-day Notice
S046
S045 2021-12-07 30-day Notice
S044
S043 2021-10-27 30-day Notice
S042 2021-10-18 30-day Notice
S041
S040
S039
S038
S037 2021-04-26 30-day Notice
S036
S035
S034 2021-02-25 30-day Notice
S033 2021-02-16 30-day Notice
S032 2021-02-08 30-day Notice
S031 2021-02-01 30-day Notice
S030 2021-02-01 30-day Notice
S029 2021-01-25 30-day Notice
S028
S027
S026 2020-11-05 Real-time Process
S025
S024
S023 2020-10-06 30-day Notice
S022 2020-10-02 30-day Notice
S021 2020-08-24 30-day Notice
S020
S019 2020-07-02 30-day Notice
S018 2020-06-16 30-day Notice
S017 2020-06-12 30-day Notice
S016 2020-06-05 30-day Notice
S015
S014
S013
S012
S011 2020-04-02 Normal 180 Day Track
S010 2020-03-16 30-day Notice
S009 2020-03-11 30-day Notice
S008 2020-03-06 30-day Notice
S007 2020-03-06 30-day Notice
S006
S005 2020-01-31 30-day Notice
S004
S003 2020-01-17 30-day Notice
S002
S001

NIH GUDID Devices

Device IDPMASupp
10810005340486 P180046 000
10810005340431 P180046 015
10810005340424 P180046 015
10810005340455 P180046 038
10810005340479 P180046 056

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.